+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Efflux-mediated drug resistance in Gram-positive bacteria

Efflux-mediated drug resistance in Gram-positive bacteria

Current Opinion in Microbiology 4(5): 509-514

Gram-positive bacteria express numerous membrane transporters that promote the efflux of various drugs, including many antibiotics, from the cell to the outer medium. Drug transporters can be specific to a particular drug, or can have broad specificity, as in so-called multidrug transporters. This broad specificity can be a consequence of the hydrophobic nature of transported molecules, as suggested by recent structural studies of soluble multidrug-binding proteins. Although the functions of drug transporters may involve both the protection of bacteria from outside toxins and the transport of natural metabolites, their clinical importance lies largely in providing Gram-positive pathogens with resistance to macrolides, tetracyclines and fluoroquinolones. A number of agents, discovered in recent years, that inhibit drug transporters can potentially be used to overcome efflux-associated antibiotic resistance.

(PDF emailed within 0-6 h: $19.90)

Accession: 034837426

Download citation: RISBibTeXText

PMID: 11587925

DOI: 10.1016/s1369-5274(00)00243-5

Related references

Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria. International Journal of Antimicrobial Agents 22(3): 205-210, 2003

Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrobial Agents and ChemoTherapy 44(10): 2595-2599, 2000

Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus. Antibiotics 2(1): 28-45, 2013

TetZ, a new tetracycline resistance determinant discovered in gram-positive bacteria, shows high homology to gram-negative regulated efflux systems. Plasmid 44(3): 285-291, 2000

Efflux pumps of gram-positive bacteria and resistance to fluoroquionolones. Antibiotiki i Khimioterapiia 46(8): 3-5, 2002

Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria. Current Drug Targets 17(6): 702-719, 2015

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrobial Agents and Chemotherapy 44(9): 2233-2241, 2000

Efflux pumps and drug resistance in gram-negative bacteria. Trends in Microbiology 2(12): 489-493, 1994

The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clinical Microbiology Reviews 28(2): 337-418, 2015

Radical scavenging and antibacterial activity of caffemides against gram positive, gram negative and clinical drug resistance bacteria. Bioorganic & Medicinal Chemistry Letters 26(24): 5943-5946, 2016

Clinical Microbiology and Infectious Diseases (ECCMID)--18th European Congress. Drug resistance among Gram-negative and Gram-positive bacteria. Idrugs 11(6): 409-411, 2008

Transcriptional attenuation controls macrolide inducible efflux and resistance in Streptococcus pneumoniae and in other Gram-positive bacteria containing mef/mel(msr(D)) elements. Plos One 10(2): E0116254-E0116254, 2016

Efflux-mediated drug resistance in bacteria. Drugs 64(2): 159-204, 2004

The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?. Drug Resistance Updates 1(2): 93-98, 2006

The carbon source influences the efflux pump-mediated antimicrobial resistance in clinically important Gram-negative bacteria. Journal of Antimicrobial ChemoTherapy 67(4): 921-927, 2012